Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- JBIO
- Price
- 17.02
- Stock movement up
- +1.08 (6.78%)
- Company name
- Jade Biosciences, Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 548.66M
- Ent value
- 521.65M
- Price/Sales
- -
- Price/Book
- 3.06
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
JBIO does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 3.06 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 32.24M |
| EPS (TTM) | -1.65 |
| FCF per share (TTM) | -1.77 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -25.00K |
| Operating income (TTM) | -64.97M |
| Net income (TTM) | -65.26M |
| EPS (TTM) | -1.65 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 50.11M |
| Net receivables | 0.00 |
| Total current assets | 201.36M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 916.00K |
| Total assets | 202.45M |
| Accounts payable | 1.35M |
| Short/Current long term debt | 747.00K |
| Total current liabilities | 22.36M |
| Total liabilities | 23.10M |
| Shareholder's equity | 179.35M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -69.71M |
| Capital expenditures (TTM) | 193.00K |
| Free cash flow (TTM) | -69.90M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -36.39% |
| Return on Assets | -32.23% |
| Return on Invested Capital | -36.39% |
| Cash Return on Invested Capital | -38.97% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 15.96 |
| Daily high | 17.11 |
| Daily low | 15.95 |
| Daily Volume | 158K |
| All-time high | 17.03 |
| 1y analyst estimate | 16.67 |
| Beta | - |
| EPS (TTM) | -1.65 |
| Dividend per share | 0.00 |
| Ex-div date | 29 Apr 2025 |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| JBIO | S&P500 | |
| Current price drop from All-time high | -0.06% | -0.89% |
| Highest price drop | -22.96% | -19.00% |
| Date of highest drop | 5 Jan 2026 | 8 Apr 2025 |
| Avg drop from high | -5.07% | -2.49% |
| Avg time to new high | 4 days | 6 days |
| Max time to new high | 22 days | 89 days |
COMPANY DETAILS
Marketcap
548.66M
Marketcap category
Small-cap
Description
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. It also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Employees
30
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner